Nearly one-third of the population has impaired voice production at some point in their lives.^1,2 Hoarseness is more prevalent in certain groups, such as teachers and older adults, but all age groups and both genders can be affected.^1-6 In addition to the impact on health and quality of life (QOL),^7,8 hoarseness leads to frequent health care visits and several billion dollars in lost productivity annually from work absenteeism.⁹ Hoarseness is often caused by benign or self-limited conditions, but may also be the presenting symptom of a more serious or progressive condition requiring prompt diagnosis and management

➡️Purpose

The primary purpose of this guideline is to improve the quality of care for patients with hoarseness based on current best evidence. Expert consensus to fill evidence gaps, when used, is explicitly stated, and is supported with a detailed evidence profile for transparency. Specific objectives of the guideline are to reduce inappropriate variations in care, produce optimal health outcomes, and minimize harm.

This guideline addresses the identification, diagnosis, treatment, and prevention of hoarseness (dysphonia). In addition, it highlights needs and management options in special populations or in patients who have modifying factors. Furthermore, this guideline is intended to enhance the accurate diagnosis of hoarseness (dysphonia), promote appropriate intervention in patients with hoarseness, highlight the need for evaluation and intervention in special populations, promote appropriate therapeutic options with outcomes assessment, and improve counseling and education for prevention and management of hoarseness. This guideline may also be suitable for deriving a performance measure on hoarseness.

➡️The Target Audience

The guideline is intended for all clinicians who are likely to diagnose and manage patients at any age with
hoarseness (dysphonia), and it applies to any setting in which hoarseness (dysphonia) would be identified, monitored, or managed.